Effect of liver fat on insulin clearance (Q46982115)

27 December 2017

title

Effect of liver fat on insulin clearance (English)

1 reference

27 December 2017

1 reference

5

Hannele Yki-Järvinen

1 reference

27 December 2017

Anna Kotronen

1

1 reference

27 December 2017

Satu Vehkavaara

series ordinal

2

1 reference

27 December 2017

Anneli Seppälä-Lindroos

series ordinal

3

1 reference

27 December 2017

Robert Bergholm

series ordinal

4

1 reference

27 December 2017

publication date

25 September 2007

1 reference

27 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

27 December 2017

volume

293

1 reference

27 December 2017

issue

6

1 reference

27 December 2017

page(s)

E1709-15

1 reference

27 December 2017

Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Insulin metabolism and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Kinetics of human connecting peptide in normal and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Degradation and Secretion of Insulin in Hepatic Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Abdominal obesity and fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Liver fat in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Determination of free and total insulin and C-peptide in insulin-treated diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Hyperinsulinemia of obesity is due to decreased clearance of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Insulin uptake by the human alcoholic cirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Splanchnic insulin metabolism in obesity. Influence of body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Quantitative study of insulin secretion and clearance in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Direct Assessment of Splanchnic Uptake and Metabolic Effects of Human and Porcine Insulin*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Relationship of triglyceride accumulation to insulin clearance and hormonal responsiveness in bovine hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

Influence of body composition on insulin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00444.2007

10.1152/AJPENDO.00444.2007

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017